A startling scene unfolded in the Oval Office Thursday as a pharmaceutical executive collapsed during a live news conference with President Trump. The event, focused on new initiatives regarding obesity drugs, was immediately halted as attention shifted to the unfolding medical emergency.
Witnesses described a man falling to the floor near the President, prompting a swift response from the White House Medical Unit. Initial reports indicated the individual was receiving immediate care, and officials quickly assured those present that he was conscious and stable.
The incident occurred during an announcement detailing a plan to make popular weight-loss medications – Ozempic, Wegovy, and Zepbound – more accessible through a new program called TrumpRx, offering the drugs for as little as $149 a month.
The abrupt pause cast a shadow over the event, which followed recent election results that saw Democratic gains. The President had previously attributed Republican losses to the ongoing government shutdown, highlighting the issue of affordability.
Pharmaceutical giants Nova Nordisk and Eli Lilly are among those participating in the program, offering discounted prices directly to consumers via a government website slated to launch next year. This move aims to address the growing demand for these medications and ease the financial burden on patients.
When the conference resumed, President Trump briefly addressed the incident, stating the man had “got a little light-headed” and was receiving medical attention. He downplayed the disruption, quickly redirecting the focus back to the drug pricing announcement and inviting the CEO of Eli Lilly to continue speaking.
Initial reports incorrectly identified the man as Gordon Findlay, a global brand director for Novo Nordisk. The company swiftly clarified that Findlay was not in attendance at the event, adding to the confusion surrounding the incident.
Those present quickly assisted the man, helping him to the ground and elevating his legs while reporters were temporarily escorted from the room. President Trump himself rose from behind the Resolute Desk to observe the situation before the cameras were cut.
This wasn't an isolated incident. Earlier this year, during a swearing-in ceremony for Dr. Mehmet Oz, a young girl fainted, also prompting a swift evacuation of reporters from the room. In that instance, officials later confirmed the girl, a family member of Dr. Oz, was also in stable condition.
The Oval Office interruptions, while unsettling, underscore the pressures and potential for unforeseen events during high-profile public appearances. The focus now returns to the implications of the new drug pricing initiative and its potential impact on healthcare accessibility.
